February 4, 2013
Crouzet J, Vieillard V, Debré P, Katlama C, Launay O, Ho Tsong Fang R, Desfontaines-Batéjat D, Marcu M, Gharakhanian S. Potential role of anti-3S antibodies in an HIV medical cure strategy ?. Oral/Poster Presentation. HIV Cure & Eradication Workshop, 24-25 January 2013; Milan, Italy . [Poster: distinguished as best poster of the Workshop]. We...
December 16, 2012
“Launching a High-Value Medical & Scientific Affairs Team” Medical & Scientific Affairs Seminar Boston Jan 2013
December 16, 2012
InnaVirVax: the Phase I/IIa clinical study of its VAC-3S immunotherapeutic vaccine in the treatment of HIV infection has achieved its primary endpoint InnaVirVax Press Release 30NOV2012
September 28, 2012
Clinical Development in Chronic Viral Disease:Reflections and Experiences from Hepatitis C and HIV Infection. Lecture @ Division of Infectious Diseases, Brigham & Womans Hospital, Harvard Medical School, 30 July 2012 Valuable role of medical affairs in new drug approval and launch Medical Affairs Executive Forum, 12-13 April 2012, Morristown NJ. https://exlpharma.boxenterprise.net/medical...
September 28, 2012
Gharakhanian S, Kotler DP. Diabetes mellitus, HIV infection, and vitamin D: time to act or time to think? AIDS 2011;25:531-3. Hézode Ch, Forestier N, Dusheiko G, Ferenci P, Pol S; Goeser T; Bronowicki J-P, Bourlière M, Gharakhanian S, Bengtsson L, McNair L, George S, Kieffer T, Kwong A, Kauffman R.S; Alam J, Pawlotsky J-M, Zeuzem S. Telaprevir and...